Tag: Pharmaceutical tariffs

  • Pharma Market Access 2025: HTA, U.S. Drug Pricing, and Tariffs

    Pharma Market Access 2025: HTA, U.S. Drug Pricing, and Tariffs

    —

    by

    wlcus_admin
    in

    Global Pharma Market Access Under Pressure Pharma market access is no longer just a regulatory hurdle, it’s a geopolitical challenge. With the EU’s new HTA regulation, U.S. pricing reforms, potential Trump tariffs, and legislative shifts in key markets, pharmaceutical access is facing cross-border disruption. Manufacturers must realign their strategies to sustain revenue and reach patients.…